MedPath

Age-related Normative Values for the Octopus 900 Perimeter

Not Applicable
Completed
Conditions
Healthy
Interventions
Device: Octopus 900 perimeter (Haag Streit AG, Koeniz, Switzerland)
Registration Number
NCT01518686
Lead Sponsor
University Hospital Tuebingen
Brief Summary

The purpose of this study is to determine normal values of the visual field (VF), corrected for age- and reaction time (RT) using the Octopus 900 perimeter and semi-automated kinetic perimetry (SKP).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
86
Inclusion Criteria
  • maximum spherical ametropia ± 6 Diopters (D)
  • maximum cylindrical ametropia ± 2 D
  • distant visual acuity ≥ 1.0 logMAR [20/20] for subjects up to 60 years, ≥ 0.8 logMAR [20/25] for subjects from 61-70 years, ≥ 0.63 logMAR [20/30] for subjects older than 70 years
  • isocoria, pupil diameter > 3mm
  • intraocular pressure (air pulse tonometer) ≤ 21mmHg
  • normal anterior segments
  • ocular fundus: normal appearance of the cup to disc ratio (CDR) ≤ 0.5, interocular difference of CDR < 0.3
  • normal macular region, vessels, and peripheral retinal examination (with undilated pupils).
Exclusion Criteria
  • amblyopia
  • strabismus
  • ocular motility disorder
  • diseases of the retina
  • glaucoma, glaucoma suspect
  • macular degeneration
  • IOP > 21 mmHg
  • abnormal color vision test (ISPP - Ishihara and Standard Pseudoisochromatic Plates = SPP)
  • history or findings of other neuro-ophthalmological disease
  • relevant opacities of the central refractive media (cornea, lens, vitreous body)
  • use of miotic drugs
  • intraocular surgery (except uncomplicated cataract surgery, more than three months previous to testing)
  • kerato-refractive surgery (LASIK)
  • drugs influencing reaction time
  • drugs indicating severe general diseases (anti-diabetic pharmaceuticals and anti-hypertensive medication were allowed for subjects older than 70 years)
  • mental diseases (for example psychosis)
  • pregnancy, nursing
  • acute infections
  • heavy smoking (>10 cigarettes /day)
  • alcohol abuse
  • diabetic retinopathy
  • coronary heart disease
  • stroke
  • migraine
  • Raynaud's syndrome
  • suspected lack of compliance

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
one armOctopus 900 perimeter (Haag Streit AG, Koeniz, Switzerland)observational study, no cohort, single group of different ages
Primary Outcome Measures
NameTimeMethod
Measurement of the full Visual Field using semi-automated kinetic perimetry.one day

additional a subgroup of 14 participants were tested at 3 separate sessions within 4 weeks.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre for Ophthalmology / Institute for Ophthalmic Research, University of Tübingen

🇩🇪

Tübingen, Baden-Württemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath